A phase II study to evaluate the efficacy and toxicity of oxaliplatin in combination with gemcitabine in carcinoma of unknown primary

Prospective Gene Signature Study Using microRNA to Identify the Tissue of Origin in Patients with Carcinoma of Unknown Primary

(2011) G. R. Varadhachary et al.   CLINICAL CANCER RESEARCH

A Phase III Randomized Trial of Gemcitabine–Oxaliplatin versus Carboplatin–Paclitaxel as First-Line Therapy in Patients with Advanced Non-small Cell Lung Cancer

(2011) Charles H. Weissman et al.   Journal of Thoracic Oncology

A Phase II Study of Outpatient Biweekly Gemcitabine-Oxaliplatin in Advanced Biliary Tract Carcinomas

(2010) A. Halim et al.   JAPANESE JOURNAL OF CLINICAL ONCOLOGY

Gemcitabine and oxaliplatin in advanced biliary tract carcinoma: a phase II study

(2008) T André et al.   BRITISH JOURNAL OF CANCER

Molecular Profiling of Carcinoma of Unknown Primary and Correlation With Clinical Evaluation

(2008) Gauri R. Varadhachary et al.   JOURNAL OF CLINICAL ONCOLOGY

Carcinoma of unknown primary with a colon-cancer profile—changing paradigm and emerging definitions

(2008) Gauri R Varadhachary et al.   LANCET ONCOLOGY